The global stem cell manufacturing market size was USD 17.05 billion in 2020 and is expected to register a CAGR of 6.8% during the forecast period.
The global stem cell manufacturing market size was USD 17.05 billion in 2020 and is expected to register a CAGR of 6.8% during the forecast period. Major factors driving market revenue growth include increasing use of stem cells to treat various diseases, rising stem cell-based research activities, and rising funding from private and public organizations for stem cell-based research. Technological advancements in cell therapy and an increased emphasis on the development of personalized medicines are contributing to market growth.
Stem cell manufacturing involves production of stem cells that can be used in cell-based research and therapeutics development. It plays a crucial role in the rapidly expanding stem cell industry. Progressing a cell-based therapeutic from pre-clinical stage production through later clinical stages and into commercial production requires scale-up, which is one of the chief drivers for stem cell manufacturing market growth.
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118264
Stem Cell Manufacturing Market: Dynamics
The stem cell manufacturing market is driven by the increasing need to understand how diseases occur. By examining stem cells from cells in bones, heart muscle, nerves, and other organs and tissue, researchers can better understand how diseases and conditions develop.
The demand for stem cell manufacturing is also increasing due to their growing use in generating healthy cells to replace diseased cells or in the development of regenerative medicine. People who might benefit from stem cell therapies include those with spinal cord injuries, type 1 diabetes, Parkinson\'s disease, amyotrophic lateral sclerosis, Alzheimer\'s disease, heart disease, stroke, burns, cancer, and osteoarthritis. Stem cells have the potential to be grown to become new tissue for use in transplant and regenerative medicine. Researchers continue to advance the knowledge on stem cells and their applications in transplant and regenerative medicine, which is expected to further boost market growth.
Before using investigational drugs in people, researchers can use some types of stem cells to test the drugs for safety and quality. This type of testing has a direct impact on drug development for cardiac toxicity testing. Over the recent past, extensive research has been carried out to test efficacy of novel drugs and therapeutics using programmed human stem cells that exhibit properties of target tissue-specific cells. For the testing of new drugs to be accurate, the cells must be programmed to acquire properties of the type of cells targeted by the drug. Tests can show whether the new drug had any effect on the cells and whether the cells were harmed.
Capital investment and unregulated framework to restrain market growth
Factors, such as the unavailability of FDA-approved stem cell treatment products, risks related to unproven stem cell treatments, and lack of government regulations in underdeveloped countries, are expected to restrain the market.
Product Outlook:
The market is divided into four categories based on product: culture media, consumables, tools, and stem cell lines. The culture media segment held largest share of the market in 2020. Increasing stem cell research and demand for stem cell therapies will drive segment growth
Applications Outlook:
The stem cell manufacturing market is segmented into academic, clinical, and cell and tissue banking based on application. Cell and tissue banking applications accounted for largest market share in 2020. Growing public demand for cord blood stem cell banking and increased understanding of potential benefits of stem cell preservation are credited for the large revenue share of the market segment.
End User Outlook:
By end user, the stem cell manufacturing market is segmented into hospitals and surgical centres, pharmaceutical and biotech firms, cell banks and tissue banks, medical institutes, clinical laboratories, and Contract Research Organisations (CROs), and other end users. Pharmaceutical and biotech firms segment accounted for largest share of the market in 2020. Growing investments in stem cell-based science, ongoing patent expiration of branded drugs, and rising patient preferences for precision and regenerative medicines are contributing to the large revenue share of the market segment.
Related Reports:
- Skin Closure Surgery Tissue Adhesive Market: https://qyresearchmedical.com/report/global-skin-closure-surgery-tissue-adhesive-market-size-share-trends-and-forecast-2022-2030/117936
- Emergency Medical Services Products Market: https://qyresearchmedical.com/report/global-emergency-medical-services-products-market-size-share-trends-and-forecast-2022-2030/117935
- Dermatological Phototherapy Lamp Market: https://qyresearchmedical.com/report/global-dermatological-phototherapy-lamp-market-size-share-trends-and-forecast-2022-2030/117934
Regional Outlook:
North America accounted for largest stem cell manufacturing market share in 2020. Regional growth is attributable to factors including presence of key market players involved in stem cell therapy development, advanced healthcare facilities, extensive R&D, supportive healthcare organizations reforms, and strong reimbursement policies in ther region. Due to state initiatives and strong research activities in the country, the U.S. is the leading country in the region.
During the forecast period, the Asia Pacific market is expected to grow at the fastest pace. Presence/implementation of supportive regulatory frameworks for stem cell research and manufacturing, ongoing expansion and modernization of healthcare infrastructure across emerging Asian economies, and the public-private partnerships to promote public awareness about stem cell-based treatment are key factors contributing to this region\'s rapid development. For instance, Medipost Co., a South Korean stem cell therapy firm, reported in January 2020 that it has completed phase 1 and 2a clinical trials for its investigational stem cell treatment of Alzheimer\'s disease.
Competitive Landscape:
Major players in the stem cell manufacturing market are Thermo Fisher Scientific (US), Merck Group (Germany), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel), among others.
Segments covered in the report:
This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2018 to 2030. The global stem cell manufacturing market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis. The report includes a detailed view of the global stem cell manufacturing market, along with changing dynamics and trends, scenarios, detailed market and regional segmentation, regional landscape, analysis and evaluation, major investments, product offerings, product launches, and details of historical, current, and projected revenues.
For the purpose of this report, Reports and Data have segmented the global stem cell manufacturing market on the basis of system type, component and region:
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118264
Stem Cell Manufacturing Market Report Scope
Segments covered By Product, Application Outlook, End User Outlook, Regional Outlook
By Product
- Stem Cell Lines
- Embryonic Stem Cells (ESCs)
- Hemopoietic Stem Cells (HSCs)
- Mesenchymal Stem Cells (MSCs)
- Multipotent Adult Progenitor Stem Cells
- Induced Pluripotent Stem Cells (iPSCs)
- Neural Stem Cells (NSCs)
- Instruments
- Bioreactors & Incubators
- Cell Sorters
- Other Instruments
- Culture Media
- Consumables
By Application Outlook
- Research
- Clinical
- Cell and Tissue Banking
By End User Outlook
- Hospitals and Surgical Centres
- Pharmaceutical and Biotech Companies
- Cell Banks and Tissue Banks
- Academic Institutes, Research Laboratories, and CROs
- Other
Regional scope
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118264/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL - http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/
https://twitter.com/qyresearchmedi